Nucleosides

2'-O-Propargyluridine is a modified nucleoside that is used in anticancer and antiviral drug synthesis. It is also used as an activator for phosphoramidites. 2'-O-Propargyluridine has been shown to have antiviral activity against herpes simplex virus type 1. This compound has also been shown to be active against cancer cells, with the ability to inhibit tumor growth in vitro and in vivo. 2'-O-Propargyluridine has a novel chemical structure and is not found in nature, which makes it difficult for the body's immune system to recognize and attack it.

ATP analog; covalent inhibitor of anthrax edema factor

2-Methylthioadenosine-5'-triphosphate (2MeSATP) is a nucleotide analogue that inhibits the synthesis of ATP by binding to the adenylate cyclase enzyme. 2MeSATP has been shown to be a potent inhibitor of neuronal death and is used as a tool in cellular research. 2MeSATP binds to guanine nucleotide-binding protein (G protein), which inhibits its activity and prevents the activation of other downstream enzymes, such as phospholipase C, which are necessary for neurotransmitter release. 2MeSATP also has an inhibitory effect on several other enzymes, including phosphodiesterases and cyclases, in cellular models and whole cells.

2'-Deoxy-a-cytidine is a nucleoside analog that inhibits the growth of bacteria by competitively binding to the 5' position of the ribose sugar in RNA. This prevents the enzyme from adding a new linkage to the ribose, which results in an irreversible blockage of RNA synthesis. 2'-Deoxy-a-cytidine has been shown to be bacteriostatic against Escherichia coli and other bacterial species. It is also able to inhibit adenosine production, although it does not show any activity against DNA synthesis. 2'-Deoxy-a-cytidine has been shown to be effective against E. coli and other bacterial species, but does not show any activity against DNA synthesis

N6-Benzoyl-5'-O-DMT-2'-O-(2-Ethoxy-2-oxoethyl)adenosine is a phosphoramidite that is used in the synthesis of oligonucleotides. It is an activator of ribonucleotides and diphosphate for RNA synthesis. Its high purity and quality make it suitable for use in the synthesis of DNA, RNA, or other nucleoside analogues.

Please enquire for more information about 5-(Furan-2-yl)-2'-deoxyuridine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Adenosine-3'-monophosphate is a nucleotide that is an important precursor in the synthesis of proteins. The ribosome, which is a large macromolecular complex that catalyzes protein synthesis, binds to the 3' end of the mRNA and adds adenosine-3'-monophosphate to the growing polypeptide chain. Adenosine-3'-monophosphate plays an important role in bacterial ribosomal RNA termination and protein synthesis. It also has sequence analysis capabilities and helps determine the sequence of subunits in the ribosome by providing a terminal nucleotide.

2,6-Diamino-9-[3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)-β-D-ribofuranosyl]purine is a protected nucleoside derivative that can potentially be used as an intermediate in the chemical synthesis of nucleoside analogs, especially for RNA or DNA oligonucleotides. This compounds has a 2,6-Diaminopurine - a purine analog structurally similar to adenine but with an additional amino group at the 2-position and a β-D-ribofuranosyl. The 3′ and 5′ hydroxyl groups of the ribose are protected with a bulky 1,1,3,3-tetraisopropyl-1,3-disiloxanediyl (TIPDS) group. This is a silyl protecting group often used to block reactivity during nucleoside synthesis.

5-Aminoallyluridine 5'-triphosphate sodium salt is a modified nucleoside that has antiviral and anticancer activity. It is a prodrug of 5-aminoallyluridine and is activated by deoxyribonucleotide ribonucleotides in the cell. This drug also can be used as an activator for other drugs, such as cytosine arabinoside, which are inactive or less active when administered alone.

Myristoyl coenzyme A lithium salt is an activator that can be used in the synthesis of Ribonucleosides and Deoxyribonucleosides. It has a high purity, which ensures high quality synthesis. Myristoyl coenzyme A lithium salt is a novel nucleotide precursor that can be used to synthesize DNA or RNA for use in anti-cancer or antiviral treatments.

2'-Deoxy-3',5'-di-O-TBDMS-uridine (dU) is an antiviral drug that inhibits viral DNA synthesis by blocking the activity of the viral enzyme ribonucleoside reductase. It inhibits the production of diphosphate, which is a precursor in DNA synthesis. This drug has shown anticancer properties and is used as a monophosphate to synthesize DNA and RNA. 2'-Deoxy-3',5'-di-O-TBDMS-uridine is also used as a phosphoramidite to synthesize oligonucleotides for use in sequencing, gene cloning, and other applications.

o-Topolin riboside is a hydroxy derivative that can be found in Helleborus niger. It has been shown to have hormone-like effects on the body, and is an endogenous compound that can be found in human blood plasma. The dry weight of H. niger leaves was increased by o-topolin riboside, and it also increased the photosynthetic activity of isolated chloroplasts from wheat leaves. The enzyme immunoassays showed that o-topolin riboside binds to both apical and basal surfaces of excised chloroplasts. This binding inhibits the decomposition of pyridine nucleotides, which are necessary for photosynthesis. The binding also inhibits the degradation of starch and glycogen, leading to an increase in carbon dioxide fixation rates.

2'-deoxyisocytidine is a nucleoside that is used in biochemical research. It can be synthesized by two methods: solid-phase synthesis and depyrimidination. 2'-deoxyisocytidine has been shown to be more efficient than other fluorescent nucleosides when used with the excimer laser technique. The stability of this compound has also been shown to be greater than other fluorescein-based compounds, which makes it an appropriate substitute when using phosphoramidite chemistry.

4-(4-Methoxyphenyl)-2-pyrimidinethiol is a synthetic nucleoside analog. It is a monophosphate that inhibits the production of RNA by inhibiting ribonucleotide reductase. 4-(4-Methoxyphenyl)-2-pyrimidinethiol has antiviral properties and can be used to treat infections caused by herpes simplex virus or HIV. This compound also has anticancer activity and can inhibit DNA synthesis in tumor cells. 4-(4-Methoxyphenyl)-2-pyrimidinethiol can also inhibit bacterial growth and is used as an antibiotic for Mycobacterium tuberculosis, Mycobacterium avium, and other bacteria.

o-Methoxytopolin Riboside is a novel phosphoramidite that can be used for the synthesis of ribonucleotides and deoxyribonucleosides. This product has antiviral and anticancer properties, as well as the ability to inhibit tumor growth by inducing apoptosis in cancer cells. It is synthesized from the natural compound o-methoxytyrosine by the addition of a phosphate group to the 3-position. The phosphate group is then modified to produce monophosphate or diphosphate forms. OMTPR has been shown to have anti-inflammatory properties and has been found to reduce inflammation in mice with colitis.

Abacavir 5'-phosphate is a nucleoside analog that inhibits the replication of the herpes virus by covalently binding to the viral DNA polymerase and blocking its ability to polymerize dNTPs. Abacavir 5'-phosphate's anti-viral potency has been shown in vivo using a model with herpes simplex virus, and it has been shown to inhibit viral replication in cell culture. The drug also reacts with cellular components such as proteins, lipids, and nucleic acids, which may lead to drug reactions. Abacavir 5'-phosphate is chemically stable, so it can be subjected to analytical methods without degradation. It is an analog of zidovudine (AZT).

Please enquire for more information about p-Coumaryl-coenzyme A including the price, delivery time and more detailed product information at the technical inquiry form on this page

5'-O-DMT-N2-phenylacetylguanosine is a novel synthetic nucleoside phosphoramidite which can be used for the synthesis of modified oligonucleotides. It has been shown to be an activator, anticancer, and antiviral agent in vitro. 5'-O-DMT-N2-phenylacetylguanosine is also a monophosphate, which can inhibit viral replication by interacting with the ribose sugar moiety of the nucleic acid strand. The antiviral activity has been demonstrated on human immunodeficiency virus type 1 (HIV-1), herpes simplex virus type 2 (HSV-2), and influenza A virus.

6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one is a synthetic nucleoside that has been shown to have potent antitumor activity in leukemia. It inhibits the synthesis of DNA by chemically binding to the enzyme that catalyzes the formation of pyrimidine nucleosides from uridine, thereby preventing RNA and DNA synthesis. 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one also reversibly binds to the template strand of dna and prevents replication. This drug is effective in treating chronic lymphocytic leukemia (CLL).

2-Amino-4-(4-chlorophenyl)pyrimidine is a antiviral agent and an inhibitor of ribonucleotide reductase. It is used for the treatment of cytomegalovirus infection, herpes zoster, and chronic myeloid leukemia. 2-Amino-4-(4-chlorophenyl)pyrimidine is also used in anticancer therapy. This drug inhibits DNA synthesis by binding to the deoxyribose moiety of ribonucleosides and diphosphates in the DNA precursor pool. The drug has been shown to be active against human lymphocytic leukemia cells as well as human erythroleukemia cells but not against normal human lymphocytes.

DMT-2²O-TC-rG(ib) Phosphoramidite is a phosphoramidite that has been modified from the natural nucleoside DMT. It is a high purity, novel anticancer agent that has shown promising results in the treatment of cancer cells. The modifications on the phosphate group allow for enhanced phosphorylation which, in turn, leads to an increase in kinase activity. This modification also increases the stability of DNA and RNA synthesis, as well as protein synthesis.

LNA-guanosine 3'-CE phosphoramidite is a novel, high purity, activated nucleoside. It is an anti-cancer and antiviral agent that is synthetically modified to include a phosphate group at the 3' position of the sugar moiety. This modification prevents viral inhibition by inhibiting viral DNA synthesis. LNA-guanosine 3'-CE phosphoramidite is also used as an anticancer agent due to its ability to inhibit ribonucleotide reductase and diphosphate reductase, which are enzymes required for DNA synthesis.

Adenosine 5′-phosphosulfate sodium salt has been used quantify pyrophosphate and in enzyme-linked bioluminescence assay for adenosine triphosphate (ATP)

4’,5’-Didehydro-2’,5’-dideoxyuridine (ddU) is a monophosphate of deoxyribonucleosides. It is an antiviral drug that was originally synthesized in the 1960s to combat viral infections. It has been used as a potential anticancer agent and as an activator for complex DNA synthesis. ddU has also been used in synthesis of phosphoramidites for DNA and RNA analogues.

2',3'-Dideoxyadenosine is a nucleoside analog that inhibits HIV replication and is a competitive inhibitor of adenylyl cyclase. This latter action reduces levels of cyclic adenosine monophosphate (cAMP)

3'-Deoxycytidine is a nucleoside analog used to treat hepatitis. It is an inhibitor of the viral enzyme reverse transcriptase and prevents the synthesis of viral DNA by blocking the formation of low-energy hydrogen bonds between the 3'-hydroxyl group and the 5'-phosphate group of deoxyribonucleotide triphosphates. 3'-Deoxycytidine can be synthesized using solid-phase methods, and has been shown to inhibit human immunodeficiency virus (HIV) in control experiments. This drug also has been shown to have anti-inflammatory effects in experimental bladder inflammation models.

2'-Deoxy-5-fluorouridine-5'-triphosphate sodium salt - 100 mM solution in water is a nucleotide analog that inhibits the synthesis of RNA. It is used for the treatment of cancer. This agent binds to DNA and prevents the formation of RNA by inhibiting the enzyme ribonucleotide reductase. 2'-Deoxy-5-fluorouridine-5'-triphosphate sodium salt - 100 mM solution in water also has a perchloric acid component, which may be responsible for its haematopoietic effects.

N-Acetyl-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxane diyl) cytidine is a novel modified ribonucleoside. It is an activator of DNA and RNA synthesis with anticancer properties. N-Acetyl-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxane diyl) cytidine has been shown to be effective against influenza A virus and herpes simplex virus type 1. NACCTC has also shown antiviral activity against HIV type 2 in cell culture. NACCTC is synthesized by phosphoramidite chemistry using the nucleoside as the starting material. This process involves the conversion of 3',5'-O-(1,1,3,3-tetraisopropyl)-1' ,

3'-Azido-3'-deoxythymidine 2,3,4-tri-O-acetyl-b-D-glucuronide methyl ester is a novel nucleoside analogue with anticancer and antiviral properties. It is an activator of ribonucleosides and deoxyribonucleosides, which are used for the synthesis of DNA and RNA respectively. 3'-Azido-3'-deoxythymidine 2,3,4-tri-O-acetyl-b-D-glucuronide methyl ester can be used to synthesize phosphoramidites and modified nucleosides. The compound has been shown to have antitumor activity in vitro against human leukemia cells.

TFA-aminoallyl-2'-deoxyuridine Phosphoramidite is a DNA precursor that is used in the synthesis of DNA. It is a novel, high quality, and purified product with a CAS number of 144253-90-7. TFA-aminoallyl-2'-deoxyuridine Phosphoramidite can be used in the synthesis of ribonucleosides, diphosphate nucleosides, monophosphate nucleosides, and deoxyribonucleosides. This product has been modified to increase its stability and inhibit degradation. TFA-aminoallyl-2'-deoxyuridine Phosphoramidite can also be used as an activator for polymerase chain reactions (PCR).

5'-O-Acetyl-2',3'-dideoxy-3'-fluoro-a-uridine is a novel nucleoside analogue that is an activator of the innate immune system. It is used for the treatment of cancer and viral infections. 5'-O-Acetyl-2',3'-dideoxy-3'-fluoro-a-uridine has been shown to have anticancer activity against pancreatic, lung, breast, prostate, colon, and leukemia cells in vitro. This drug also inhibits influenza virus A/WSN/33 replication in cell culture by blocking the RNA polymerase complex at the initiation stage. 5'-O-Acetyl-2',3'-dideoxy-3'-fluoro-a-uridine has also been shown to be active against herpes simplex virus type 1 (HSV1) and human immunodeficiency virus type 1 (HIV1).

Coenzyme and regenerating electron donor in catabolic processes

1,5-Anhydro-2,3-dideoxy-2-(N2-isobutyrylguanidin-1-yl)-D-glucitol is a novel, activator ribonucleosides deoxyribonucleosides diphosphate phosphoramidites modified anticancer antiviral monophosphate nucleosides synthetic high purity CAS No. It has been shown to have anticancer and antiviral properties. This compound also inhibits the replication of HIV in vitro.

Methyluridine is a derivative of uridine that is used in the synthesis of pyrimidine nucleotides. This drug is also an inhibitor of orotidine 5′-monophosphate decarboxylase, which converts orotic acid to uracil. The conformational properties of methyluridine have been studied and found to be similar to those of other purine derivatives, such as adenine and guanine. In addition, methyluridine has been shown to inhibit the growth of typhimurium and increase the production of uracil in human lymphocytes. Methyluridine is metabolized by hydroxylation in liver microsomes, yielding 6-carboxylic acid.

4-(2-Methoxyethylamino)-2-(methylthio)pyrimidine-5-carboxylic acid (4MEAP) is a novel phosphoramidite that can be used in the synthesis of ribonucleosides and deoxyribonucleosides. 4MEAP has antiviral activity, cytotoxicity, and anticancer properties. It may also have potential as an anti-inflammatory agent due to its ability to inhibit prostaglandin production.

Adenosine 2',3'-O-phenylboronate is a nucleoside that is used as an antiviral and anticancer drug. It is used in the treatment of AIDS, leukemia, and lymphoma. Adenosine 2',3'-O-phenylboronate inhibits viral replication by preventing the formation of viral DNA. This nucleoside has also been shown to have antitumor properties and can be used to inhibit cancer cell growth. br>br> Adenosine 2',3'-O-phenylboronate can be modified with phosphoramidites, which allow for the synthesis of modified adenosine 2',3'-O-phenylboronates. These modifications include substituting one or more hydrogen atoms with a variety of substituents, including fluorines, chlorine, bromines, nitro groups, alkyl groups, alkoxy groups and others. This modification provides for a novel type of anti

2',3'-Dideoxy-3'-fluoroadenosine (ddFdA) is an antiviral drug that has been shown to be effective against HIV and other viruses. It is a synthetic nucleoside analogue of the natural purine adenosine. ddFdA inhibits the synthesis of viral RNA and DNA by competitively inhibiting the enzyme ribonucleotide reductase, thereby blocking DNA synthesis. The drug has shown significant activity in humans with immunodeficiency, but also has toxic effects on lymphocytes. ddFdA is synthesised from 2',3'-dideoxyadenosine (ddAdo), which is produced by the action of adenosinase on adenosine. In humans, ddFdA is converted to dideoxyadenosine triphosphate (ddATP), which inhibits cellular proliferation.

5'-Deoxy-5'-fluorothymidine is a cytotoxic agent that inhibits the synthesis of DNA by binding to the enzyme thymidylate synthase and preventing the formation of thymine nucleotide. 5'-Deoxy-5'-fluorothymidine has shown to be effective against herpes simplex virus, murine bone, and tissue culture cells. This drug also inhibits cellular proliferation in vitro and can be used in chemotherapy treatment. 5'-Deoxy-5'-fluorothymidine is synthesized from guanine by an enzyme called deoxyguanosine kinase. The biosynthesis of this drug involves two steps: conversion of guanine to xanthosine monophosphate (XMP) and conversion of XMP to 5'-deoxy-5'-fluorothymidine (dFTP).

DMT-2²O-TC-rC(ac) Phosphoramidite is a novel nucleoside that has been modified with a 2,2'-O, TC-rC(ac) group. This compound is an analogue of the natural nucleoside cytidine and can be used in both DNA and RNA synthesis. DMT-2²O-TC-rC(ac) Phosphoramidite is phosphorylated by ATP to form diphosphate, which is then incorporated into DNA or RNA. The CAS number for this compound is 1219089-87-8.

2'-Deoxy-a-guanosine is a nucleoside that is modified by the substitution of its ribose sugar with deoxyribose. It is used in anticancer and antiviral research. This chemical has been shown to inhibit DNA synthesis and RNA polymerase activity. 2'-Deoxy-a-guanosine has also been shown to have an anti-inflammatory effect, which may be due to its inhibition of prostaglandin synthesis.

Biotin-11-uridine-5'-triphosphate, lithium salt (BUP) is a nucleoside analog that has been modified to allow the incorporation of BUP into DNA. The modification of BUP with lithium salts allows for the covalent attachment of BUP to DNA. This incorporation of BUP into DNA prevents the polymerase from binding to DNA and thus inhibits replication. Biotin-11-uridine-5'-triphosphate, lithium salt (BUP) has demonstrated anticancer and antiviral activity as well as being novel and high quality.

2'-Deoxyadenosine-5'-diphosphate sodium salt is a nucleotide that is involved in the synthesis of DNA. It is a structural analog of adenosine-5'-diphosphate and can be used as an experimental tool to study metabolic disorders. 2'-Deoxyadenosine-5'-diphosphate sodium salt binds to p2y receptors and blocks their activation, which inhibits cellular energy metabolism. This compound is structurally similar to adenosine-5'-triphosphate, but has been shown to inhibit the expansion of cells when heated, unlike adenosine-5'-triphosphate. 2'-Deoxyadenosine-5'-diphosphate sodium salt also inhibits cell proliferation in cancer cells and may have potential as a therapeutic agent for bowel disease.

L-Guanosine is an enantiomer of adenosine. It has been shown to be effective in the treatment of autoimmune diseases and viruses, such as HIV. L-Guanosine is activated by phosphorylation, which leads to its binding with DNA and inhibition of viral replication. L-Guanosine is also a potent inhibitor of mammalian cell proliferation. It binds to the enzyme adenosyltransferase, thereby inhibiting the production of nucleotides, which are necessary for DNA synthesis. This inhibition causes cell death due to lack of DNA synthesis and protein production.

5-Formyl-2'-O-methyluridine is a nucleoside that can be used as an antiviral and anticancer agent. It is a novel modified monophosphate nucleotide analog with high purity and high quality. 5-Formyl-2'-O-methyluridine has shown to inhibit the growth of cancer cells in vitro and to reduce tumor size in vivo. It also inhibits viral replication by inhibiting viral DNA synthesis. 5-Formyl-2'-O-methyluridine has been shown to be an effective inhibitor of HIV and HSV, where it has been found to inhibit the synthesis of viral RNA, which prevents the virus from replicating.

2'-O-Methylguanosine-5'-triphosphate sodium salt is a nucleotide that is synthesized by the phosphorylation of guanosine at the 5' position. It has been shown to have significant activation of cardiac protein synthesis and translation. This nucleotide has also been shown to stabilize RNA in vitro, which may be due to its ability to activate adenylate cyclase activity. 2'-O-Methylguanosine-5'-triphosphate sodium salt is a potent inhibitor of hepatitis B virus replication, but does not inhibit the replication of other viruses.

6-Methyl-thio-guanosine is a guanine analog that has been used for the treatment of asthma. It was found to be effective in reducing the number of neutrophils and responsiveness of these cells to stimuli. 6-Methyl-thio-guanosine is able to reduce the number of neutrophils in the airway and decrease the amount of sputum produced by patients with chronic obstructive pulmonary disease. 6-Methyl-thio-guanosine also prevents the release of mediators from these cells, which are important in inflammation. This drug has been shown to have an effect on bronchial epithelial cells, slowing their growth and increasing their ability to resist damage. 6-Methyl-thio-guanosine can be administered by inhalation or orally, through microlenses or expansion devices, or by suctioning bronchial secretions. Treatment may also involve injection directly into lung tissue using a bron